CD8A and neoplasm: As the density and pattern of the immune infiltrate in tumor tissues has been repeatedly associated with patient outcome in a wide range of malignancies, including HPV-associated HNSCC, high densities of CD8+ T cells and especially B cells or the presence of HPV-specific T cells within the tumor tissue might be considered possible biomarkers in treatment deintensification clinical trials.